PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1070390
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1070390
The global cell & gene therapy cold chain logistics market is estimated to be worth US$ 1,308.5 million in 2020. Cell & Gene Therapy Cold Chain Logistics market is expected to expand at a 16.6% CAGR during the forecast period.
Market Introduction
The cold chain for a cell or gene therapy is the sequence of transportation events required to maintain the temperature within approved specifications from the time the formulated bulk material is manufactured until the packaged product is delivered to the end-user. Cold chains for pharmaceutical and biologic product distribution (shipping/storage) have been well-established for decades, employing platform processes and technologies to ensure efficient product storage and distribution based on the product's temperature requirements, whether room temperature, refrigerated or frozen (usually 0 to -40°C).
Market Dynamics
Chronic diseases such as cancer, cardiovascular disease, and neurological disorders are on the rise, which is fueling the market growth of the cell & gene therapy cold chain logistics market. The growing elderly population, as well as their vulnerability to chronic diseases, is also adding to this trend since treatment demands have risen significantly. In addition to this, the Global Cell & Gene Therapy Cold Chain Logistics Market is expected to benefit from rapidly rising clinical trials and FDA approvals toward legalizing cell and gene therapy. Increasing approvals are supporting the rising demand for cell and gene therapy products, as well as their transportation to various regions of the world, favorably impacting the growth of the global cell and gene therapy cold chain logistics market in the forecast period. Moreover, due to the lucrative nature of the market, many international as well national players are entering the industry for storing and preserving cell & gene therapy products in the cold chain, this is expected to further facilitate the growth of global cell & gene therapy cold chain logistics market during the forecast years.
Segmentation Analysis
The global cell & gene therapy cold chain logistics market is segmented by services, components, transportation mode, temperature, end-user, regional distribution, and competitive landscape. Based on components, cryogenic shippers are expected to hold the largest share of the global market during the forecast years. This is primarily driven by the increasing demand for storing and transporting cells, tissues, and various biological samples which requires extreme cold storage, for storing and transporting. This is also expected to provide high growth prospects for Global Cell & Gene Therapy Cold Chain Logistics Market in the forecast period.
Competitive Landscape
Players compete and collaborate to achieve a significant market share in this highly competitive market. Expansion into newer, undiscovered areas, new product releases, and operational efficiency initiatives are all important elements in market growth. Because of the increased demand for cold chain logistics services, the industry has seen several facility/capability expansions and acquisitions, indicating the growing interest of stakeholders in this type of supply chain.
Given recent technological breakthroughs and advances, as well as the steadily increasing demand for biopharmaceuticals, the reliance on the cold chains are expected to grow significantly, requiring logistics service providers to consider, devise, and implement flexible business strategies and operational models to meet future demands. For instance, in 2021, Genentech, Takeda, Adaptimmune, and Vineti formed a collaboration to promote standards and a modern patient id for advanced therapies. Major companies are likely to benefit from such advances in the cell & gene therapy cold chain logistics market.
Key features of the study:
This proposed research study on Cell & Gene Therapy Cold Chain Logistics market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2021-2027), considering 2020 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Cell & Gene Therapy Cold Chain Logistics market.
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Cell & Gene Therapy Cold Chain Logistics market.
Impact of COVID-19 on Cell & Gene Therapy Cold Chain Logistics market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Cell & Gene Therapy Cold Chain Logistics market post-COVID will also be covered.
In order to give the users of this report a comprehensive view on the Cell & Gene Therapy Cold Chain Logistics market, we have also included competitive landscape and key innovator analysis for the Cell & Gene Therapy Cold Chain Logistics market
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Cell & Gene Therapy Cold Chain Logistics market.
In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
The global Cell & Gene Therapy Cold Chain Logistics market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
Global Cell & Gene Therapy Cold Chain Logistics Market Key Players
AmerisourceBergen Corporation (World Courier)
United Parcel Service (Marken)
Catalent, Inc.
BioLife Solutions, Inc.
Cryoport, Inc.
Atelerix Ltd.
Biostor Ltd.
Thermo Fisher Scientific Inc.
Life Science Group Ltd (LSG)
Yourway Biopharma Services Company
Bertelsmann SE & Co. KGaA (Arvato Supply Chain Solutions)
Global Cell & Gene Therapy Cold Chain Logistics Market by Component
Cryogenic Storage Freezers
Ultra-Low Freezers
Cryogenic Shippers
Cold Chain Management Systems
Cryogenic Packout Kits
Shipment and Storage Medium
Others
Global Cell & Gene Therapy Cold Chain Logistics Market by Services
Storage
Packaging
Transportation
Global Cell & Gene Therapy Cold Chain Logistics Market by Temperature
Cryogenic
Refrigerated
Ambient
Others
Global Cell & Gene Therapy Cold Chain Logistics Market by Transportation Mode
Water
Air
Ground
Global Cell & Gene Therapy Cold Chain Logistics Market by End User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
Global Cell & Gene Therapy Cold Chain Logistics Market by Region
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa